CareLit · DOI-Nachweis · Klinische Pädiatrie
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
DOI 10.1055/s-0034-1374834
Bibliografische Angaben
Nachweis in CareLit
Autor:innenV Münch, N Hasan, M Schirmer, S Mirjam Eckhoff, KM Debatin, LH Meyer
ZeitschriftKlinische Pädiatrie
Ausgabe05/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
As novel therapeutics are urgently needed for treating acute lymphoblastic leukemia (ALL) we established a poly-agent chemotherapy regimen in our NOD/SCID/huALL xenograft model investigating its effectivity on different patient-derived xenograft (pdx) ALL samples, which further can be used to evaluate novel substances in combination modalities. ALL carrying recipients receiving multi-agent chemotherapy showed a sign…
Zitieren
Zitierempfehlung
V Münch, N Hasan, M Schirmer, S Mirjam Eckhoff, KM Debatin, LH Meyer (2014) In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0034-1374834
Mit CareLit weiterarbeiten